BIOSYNTIA ApS: Financial statements 2018
CVR: 34892970
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -2,671,636 and a net result of DKK -9,431,042 compared with DKK -3,210,394 the year before. Equity in the 2018 report amounted to DKK 25,167,776. The solvency ratio was 85%. The company had 18 employees in the financial year.
- Gross Profit
- DKK -2,671,636
- Profit/Loss
- DKK -9,431,042
- Equity
- DKK 25,167,776
- Total Assets
- DKK 29,605,307
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -2.7 mio. | -9.4 mio. | 25.2 mio. | 18 |
| 2017 | - | 2.2 mio. | -3.2 mio. | 4.8 mio. | 14 |
| 2016 | - | 619 t. | -2.8 mio. | 8 mio. | 8 |
| 2015 | - | 1.2 mio. | -1.7 mio. | 3.9 mio. | - |
| 2014 | - | 1.6 mio. | -4 t. | 48 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
BIOSYNTIA ApS has published its annual report for 2017. Gross profit came to DKK 2,197,797, and the net result was DKK -3,210,394.
As of April 24, 2018, Joško Bobanović has joined the board of directors of BIOSYNTIA ApS.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees (2018). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.